Dr. Pkdeb Kishore Deb PhD
Date of Joining:
2nd August, 2023
-
Department of Pharmaceutical Sciences and Technology, BIT Mesra, Ranchi, 835215, Jharkhand, India
-
8822667507|8822667507
-
pran.kishore.deb@bitmesra.ac.in
Research Areas
- Design, Synthesis, and Development of Novel Chemical Entities (NCEs) targeting Adenosine Receptors, TB, Inflammation and Cancer.
Work Experience
- Teaching: 12 Years
- Research: 10 Years
- Industry: 12 Years
Pkdeb
"
width="406"
height="371"
loading="lazy"
>
Academic Profile
Award and Honours
Leadership & Institutional Service
Teaching & Mentorship
Award and Honours
Recognition - World Top 2% Scientists (Single Year Category 2020-2023): Compiled and Enlisted by Stanford University, published by the Elsevier Database https://elsevier.digitalcommonsdata.com/datasets/compare/btchxktzyw
APP’s Innovative Researcher Award 2019. Awarded by “Association of Pharmacy Professionals (APP)” at APP 1st Indo-Jordan Conference, “Global Trends in Drug Design, Discovery, and Pharmaceutical Sciences”, School of Pharmaceutical Sciences, VELS University,
First prize-IMU Best Faculty Achievement Award under e-Learning Innovation. March 13, 2015, International Medical University (IMU), Kuala Lumpur, Malaysia.
Intellectual Property Rights (IPR)
-
Substituted 7-amino-3-(substituted benzoyl) indolizine-1-carboxylates as anti-tubercular agents.
- Date:
-
5-(substitutedphenyl)-7-imino-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agents.
- Date:
-
Adenosine receptor activity of methyl/ethyl 3-(substituted benzoyl)-6, 8-dimethylindolizine-2-substituted-1-carboxylates.
- Date:
-
2-4-Disubstituted-thieno[2,3-d]pyrimidine derivatives and uses thereof.
- Date:
-
{5-chloro-2-(2-(3-(substitutedphenyl)-1,2,4-oxadiazol-5-yl)ethyl)phenyl}(phenyl)methanones as larvicidal agents.
- Date: